6,952 reports of this reaction
3.0% of all Tecfidera reports
#5 most reported adverse reaction
FATIGUE is the #5 most commonly reported adverse reaction for Tecfidera, manufactured by Biogen Inc.. There are 6,952 FDA adverse event reports linking Tecfidera to FATIGUE. This represents approximately 3.0% of all 233,327 adverse event reports for this drug.
Patients taking Tecfidera who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for Tecfidera, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for Tecfidera:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 6,952 FDA reports for Tecfidera. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.0% of all adverse event reports for Tecfidera, making it a notable side effect.
If you experience fatigue while taking Tecfidera, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.